Deka R&D Corp.

US FDA has been working with academic scientists, the US military and device companies for the past decade on implants that might interface with the nervous system, allowing a paralyzed patient or amp

A device used in cardiac surgery and a powered-arm prosthesis will both be regulated as moderate-risk, class II devices, US FDA affirmed in a pair of Oct. 17 Federal Register notices. Both classificat

Deka R&D Corp. President Dean Kamen says 18 months is too long for “innovative technology” like the Deka LUKE prosthetic arm – an artificial limb with fingers sensitive enough to pick up and move

Patients with end-stage renal disease now have the option of home-based therapy using Amia, an automated peritoneal dialysis system with two-way remote connectivity from Baxter International Inc.